|Bid||0.141 x 950000|
|Ask||0.160 x 850000|
|Day's Range||0.140 - 0.141|
|52 Week Range||0.035 - 0.332|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, British Columbia, March 01, 2018-- Breathtec Biomedical Inc. is pleased to announce the appointment of Christopher J. Moreau as Chief Executive Officer effective March 1, 2018.. Moreau is a ...
VANCOUVER, British Columbia, Jan. 25, 2018--. Please note this is an Official Company News Release.. Breathtec Biomedical Inc. is pleased to report on the development of its Breathtec Disease Detection ...
Breathtec Biomedical Inc. announces that effective immediately, Guy La Torre has resigned as Director and Chief Executive Officer of the Company to pursue other ventures. The Company wishes Guy the best ...
Breathtec BioMedical, Inc. , a medical diagnostics company focused on developing, in-licensing and commercializing proprietary, innovative breath analysis devices for the early detection of infectious ...